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Vaccines recommendations are available for both healthcare pro-
fessionals and the general public, but although the vaccination is 
the most effective method to prevent infectious diseases, the cov-
erage is still behind the recommended rate. In Italy, according 
to a recent study, the anti-flu vaccination rate among healthcare 
worker range between 9% to 30%. The aim of our study was to 
identify knowledge, attitude and behaviours regarding influenza 
vaccination among community pharmacists in order to increase 
the coverage rate among healthcare professional. “PErCEIVE 
(Pharmacist Perception on Influenza Vaccine) in Umbria” was a 
cross sectional survey among community pharmacists in Umbria 
conducted between 16th November 2015 to 29th February 2016. The 
questionnaire was anonymous, on-line self-administered survey. 
Statistical analysis were performed using STATA/SE 12 software. 
The response rate was 28.91% (n = 72/249). Among the studied 
population 76.39% (n = 55) had never performed influenza vaccine 
during the previous 5 years. Regarding source of information, only 
15.28% of the subjects (n = 11) consulted the scientific publica-
tions, vs 52.78% (n = 38) who did not show any kind of interest 
upon the influenza vaccine. Our results show a low attitude to be 
vaccinated among pharmacists together with a low grade of aware-
ness regarding the important role that pharmacists might play in 
order to reduce influenza burden, to promote health literacy among 
their patients and to decrease the risk of patients infection. Phar-
macists might be crucial healthcare workers involved in health pro-
motion, in vaccines’ uptake and practices progression. 
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Introduction
Seasonal influenza is an airborne acute viral infection 
caused by influenza virus  [1]. It is highly contagious, 
and despite the fact that, in the majority of the case, the 
progress is mild, influenza is responsible for about 3 
to 5 million cases of severe illness worldwide [1], and 
about 5,000-70,000 death in Europe  [2]. In particular, 
in industrialized countries most deaths occur among 
people age 65 or older  [3]. Vaccines recommendations 
are available for both healthcare professionals and the 
general public, but although the vaccination is the most 
effective method to prevent the disease, also in the high 
risk group, the coverage is still behind the recommended 
rate. In Italy, the vaccination coverage for the Anti-flu, 
has fallen from 68.3 per 100 inhabitants during the 2005-
2006 vaccination campaign, to 49.9 per 100 inhabitants 
in 2015-2016  [4]. It is extremely below the minimum 
established target (75%), set by the National Immuni-
sation Plan. Thanks to the last National Immunisation 
Plan (2017-2019), the immunisation schedules are rec-
ommended for children, adolescents and adults with the 
regular update (through life approach), and vaccines 
are included in the basic levels of care (LEA-Livelli 
Essenziali di Assistenza) [5]. For example, in Italy, the 
Anti-flu vaccine is recommended for: i) general popula-
tion with some specified chronic diseases, responsible 
for severe complication or death; ii) people aged 65 or 
more; iii) pregnant women who are in the second or third 
trimester during the beginning of influenza season; iv) 
professionals who are exposed to animals responsible 
for infection; v) professionals of public security inter-
est; vi) family members of at high risk people; and last 
but not least vii) healthcare professionals [5]. Actually, 
anti-flu vaccines among healthcare workers is strongly 
encourage because it can prevent potential flu spread 
to patients, with unstable health status that can rapidly 
deteriorate, or to other professionals reducing the work 
absenteeism  [6]. Moreover, the healthcare vaccination 
might serves as a positive model and promoter in influ-
enza vaccination campaigns.
However, despite the recommendation, the vaccine cov-
erage among healthcare workers is still low. The mini-
mum objectives established in the US by Healthy People 
2020 is 90% of influenza vaccination coverage among 
healthcare personnel  [7]. In Italy there are two levels 
of vaccination coverage: 75% established as minimum 
rate to reach, and 95% as optimal goal  [5]. Although 
the Anti-flu vaccine coverage rate is high heterogene-
ous among Europeans Countries, it is significantly under 
the recommended rate, ranging from 10% to 50% [8]. 
In Italy, according to a recent study conducted by Ali-
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cino et al., the anti-flu vaccination rate among healthcare 
worker was around 30% among physicians, 11% among 
nurses and 9% among other clinical personnel during the 
vaccine campaign 2013/14 [9].
This significant low vaccine coverage seems to have 
serious consequences both individually and collec-
tively. Even more serious is also the low perception of 
the importance of influenza vaccination among health 
care workers. Actually, Verger et al. in a recent National 
Cross-sectional Survey in Frances evidenced that only 
54.5% of General Practices were “very confident” with 
vaccine utility, and only 26.2% of them were “very con-
fident” with vaccine safety [10]. 
The aim of our study is to understand the determinants 
related to influenza vaccination uptake among communi-
ty pharmacists. Pharmacists’ role is not only to dispense 
drugs, but also they play a key role to provide appro-
priate consultations to the patients, to address patients’ 
doubts among medications or vaccines  [11]. However, 
community pharmacies are not always included in the 
vaccine campaign despite many patients receiving their 
medications and tips. Identification of knowledge, at-
titude and behaviours regarding influenza vaccination 
among community pharmacists is important to regulate 
the efforts need to increase the coverage rate among 
healthcare professionals and among general population. 
Moreover, understanding the reasons of vaccine hesi-
tancy among pharmacists could identify the underlying 
reasons of vaccination campaigns’ failure, other than to 
tailor public health strategies designed to increase the 
healthcare worker vaccinations’ attitude. 
Methods
“PErCEIVE (Pharmacist perception on Influenza Vac-
cinE) in Umbria” was a cross sectional survey among 
community pharmacists in Umbria. The survey was con-
ducted between 16th November 2015 to 29th February 
2016 on community pharmacists working in Umbria. 
The questionnaire was anonymous, on-line self-admin-
istered survey. We used the validated questionnaire pre-
viously developed by the Medical Residents in Hygiene 
and Preventive Medicine of the Italian Society of Hy-
giene, Preventive Medicine and Public Health (S.It.I.-
Società Italiana di Igiene, Medicina Preventiva e San-
ità Pubblica) [12]. The questionnaire was first designed 
aimed to investigate the knowledge and attitude of the 
Italian Medical Residents in Hygiene. We decided to use 
the same questionnaire because of the similarity of the 
aims, and due to the correspondence of target groups’ 
characteristics. Actually, both medical residents and 
pharmacists were Italian, with not cultural and language 
differences, moreover both this two professions catego-
ries are healthcare workers with a trustworthy relation-
ship with the patients. We just replaced the term “medi-
cal residency” with “pharmacist” in the questionnaire. 
We invited the community pharmacists by sending them 
an email. The enrolment was voluntary base. Data were 
collected by an electronic survey, administered on-line 
(Google Moduli®).
The survey, with lasted no more than 20 minutes, con-
tained 21 questions soliciting information about: demo-
graphics characteristics; personal experience of influ-
enza; personal influenza immunization history; reasons 
for getting vaccination and for recommending it to the 
patients; potential barrier or reasons to refuse influenza 
vaccination; their recommendation for patients regard-
ing influenza vaccine; main sources of information on 
anti-flu vaccine; readiness in vaccination campaign 
participation. The questionnaire had mainly multiple-
choice questions. Box for comments was also provided 
for some section.
Statistical analysis
Statistical analysis were performed using STATA/SE 12 
software. Chi-square test (for categorical variables) and 
Student’s t test (for continuous variables) were used for 
examining statistical significance. Pearson’s correlation 
coefficient was also used to assess linear dependences 
between variables. We used the two-tailed version of all 
tests, and the p-value ≤ 0.05 were considered statistically 
significant.
Ethical approval
All data collected was recorded on a computerized da-
tabase in an anonymous way; the file was protected by 
password, known only to researchers. Written informed 
consent was obtained from all participants. The “PEr-
CEIVE in Umbria” study received ethical approval from 
the local ethics committee of the University of Perugia 
(Comitato Universitario di Bioetica), Reference Num-
ber: 2015-013.
Results
Characteristics of the population
The population constituted of 249 community phar-
macists who received the invitation mail, 72 of which 
agreed to fill the questionnaire, with a response rate of 
28.91%. Out of 72 participants, 40 were female (55.56 
%) and 32 were male (44.44 %), with a mean age of 
45 ± 12.99 years. The 45.83% of the subjects self-re-
ported a good or discreet knowledge related to influ-
enza vaccine (Tab. I). In the majority of the case, the 
respondents (n = 46, 63.89%) had contracted the In-
fluenza Like Illness (ILI) at least once during the past 
5 years. However, 43.06% (n  =  31) did not perceive 
themselves as a risk subjects, despite the profession-
al exposure. Among the studied population 76.39% 
(n = 55) had never performed influenza vaccine during 
the previous 5 years. Among the only 5 pharmacists 
who performed anti-flu vaccination during the last 
year, the reason was the awareness to be a risk subject, 
due to the professional exposure. Inversely, among the 
subjects who had not performed the vaccination, the 
main reasons were: they believe that the low risk asso-
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ciated to the disease do not justify the vaccine need and 
because they did not consider themselves as a relevant 
element in the chain contagion both for relatives and 
for patients. Thirdly, they did not consider vaccination 
because of their age (younger than 65 years). Regard-
ing source of information, 52.78% (n = 38) who did 
not show any kind of interest upon the influenza vac-
cine. Among them who search information (n = 23), 
65.22% (15/23) of the subjects consulted institutional 
sources (scientific publication or institutional reports/
web pages). Only 19.44% (n = 14) are intended to up-
date their influenza vaccination during the following 
campaign. Among them in 50% (n = 7) of the cases, 
the reason was the awareness to be a high-risk subject, 
the remaining 50% (n = 7) recognize their responsive-
ness in contagion chain. Regarding the possibility to 
recommend the vaccination 25.00% (n  =  18) of the 
subject did not invited people to get influenza vaccine, 
however the percentage decrease to 18.06% (n = 13) 
considering the intention to promote vaccine during 
the next campaign. 
Statistical analysis
Had been performed influenza vaccine, during the last 
5 years, is statistical significant associated with consid-
er themselves as risk subjects rho di Spearman = 0.33 
(p = 0.005). This data was also confirmed considering 
who performed vaccination during the previous year 
(rho di Spearman = 0.26 (p = 0.028). At the same time, 
the awareness to be a risk subjects is statistical associ-
ated with the intention to get a vaccine during the fol-
lowing influenza campaign, rho di Spearman  =  0.39 
(p = 0.0006). The degree of self-reported knowledges, 
regarding influenza and influenza vaccine, is statistical 
associated with the source of information. Moreover, the 
intention to be vaccinated next year is also statistical as-
sociated with had performed influenza vaccine during 
the last 5 years and previous year. Interestingly, who 
have the intention to be vaccinated next year is also asso-
ciated with the propensity to recommend vaccine to their 
patients. Actually, who consult scientific publication or 
institutional documents/web sites reported a higher de-
gree of knowledges in a statistical significant manner, 
rho di Spearman = 0.52 (p = 0.012). Furthermore, the 
high self-reported degree of knowledge is also associat-
ed with having received the request for information from 
general population, rho di Spearman = 0.29 (p = 0.014). 
Having received the request for information is also as-
sociated with the attitude to recommend vaccination, rho 
di Spearman = 0.39 (p = 0.0006); and to be incline to 
suggest vaccination for the next campaign, rho di Spear-
man = 0.25 (p = 0.035). The duration of years of work 
is statistical associated with the vaccination performed 
last year, actually who get vaccine the previous year had 
33.2 ± 9.73 years (mean ± standard deviation) of work 
(p = 0.0056) (Tab. II).
Discussion 
In Umbria, during the 2011/14 season, influenza vaccine 
coverage rate in the population aged between 18 and 64 
years with at least 1 risk factor was 19.4%. Among indi-
viduals over 65 years, the coverage rate was 62.8 per 100 
inhabitants in 2015/16 season, the highest rate among the 
Italian regions. However, the national coverage rate is 
still 20-points percentage less compared to the 2005/06 
season (2005/06 season was the period with the highest 
coverage rate since the flu-vaccine introduction in Italy, 
with a coverage rate of 68.3% among people over 65 
Tab. I. Characteristic of studied population. Number and percentage 
in parenthesis n (%).
Gender Male Female




33/72 (45.83) 39/72 (54.17)
ILI in the previous  
5 years
Yes No
46/72 (63.89) 26/72 (63.89)
Get a vaccine  
last year
Yes No
5/72 (6.94) 67/72 (93.06)
Get a vaccine  
during last 5 years
Yes No
17/72 (23.61) 55/72 (76.39)
Perception to be  
a risk subject
Yes No
38/72 (52.78) 34/72 (47.22)
Search information  
on anti-flu vaccine
Yes No
23/72 (31.94) 49/72 (68.06)
Institutional source  
of information
Yes No
15/23 (65.22) 8/23 (34.78)
Tab. II. Correlation between consider themselves as risk subjects and vaccine behaviour and between had received request of information 
regarding anti-flu vaccination and attitude.
Be vaccinated last 5 years Be vaccinated last year
Intention to be vaccinated 
next year








Had received request of 
information 
Degree of influenza 
knowledges
Attitude to recommend 
vaccination
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years)  [13]. Actually, Ministry of health, in collabora-
tion with Istituto Superiore di Sanità, set up several ac-
tivities in order to ensure influenza control. In particular 
the development of InfluNet (National sentinel influenza 
surveillance system), InfluWeb (community based par-
ticipatory surveillance system) and Flunews (a report 
combining information from different sources)  [14]. 
However, despite the high efforts, the low influenza 
vaccine coverage is probably due to a lack of influenza 
vaccine confidence after the 2009 pandemic  [15]. Our 
survey confirmed that many healthcare workers, specifi-
cally pharmacists, do not consider anti-flu vaccination 
relevant to prevent patients/relatives’ infection. 
This is not the first study evaluating the vaccine hesitan-
cy among healthcare professionals; however, the origi-
nalities of the present study are the ability to investigate 
the knowledge and the attitude such as the selection of 
the studied population. Although the questionnaire was 
already described in literature, it is for the first time used 
to assess the behaviour and willingness on influenza 
vaccine among Italian pharmacists. One of the most im-
portant result of “PErCEIVE in Umbria” study is that 
among pharmacists there is the wrong assumption that 
pharmacists are not professionals at high risk. Actually 
5.56% of the subjects (n = 4) refuse the influenza vac-
cine, because younger than 65 years. These statements 
confirm the lack of appropriate knowledge regarding 
the definition of groups for whom the influenza vac-
cine is recommended. Previous studies has been dem-
onstrated that people failed to be vaccinated because of 
the lack of healthcare workers’ recommendations [16]. 
Although 59%-81% of adults in USA used internet to 
acquire health information  [17, 18], healthcare profes-
sionals is the most important information source among 
patients  [19]. Moreover, Johnson and colleagues in a 
recent survey conducted among general population and 
GPs found that both groups are more likely to discuss 
about vaccinations during well-care visits [20]. It seems 
likely that it might be the same also in pharmacies, dur-
ing drugs’ dispensation for mild diseases [21]. 
Moreover, Johnson et al. also indicated that influenza 
vaccine is less recommended compared to tetanus and 
pneumococcal  [20]. This may indicate the absence of 
routinely vaccines’ recommendations system that might 
reduce the missed opportunities to educate patients on 
immunizations or to update their immunization status. 
The missed opportunities for flu vaccine is particularly 
high (confirmed by the low coverage rate reached in 
every season), and a reminder/recall system for physi-
cian can increase GPs awareness on both their patient’s 
vaccination status and vaccine indications.
Although anti-flu vaccination is universally recognized 
as an essential element of disease prevention, our results 
show a low propensity to be vaccinated among pharma-
cists. The consequences of these results are basically the 
urgent need to identifying the reasons responsible for 
low vaccine coverage, even in healthcare workers. Fur-
thermore, it is crucial to identify strategies to increase 
awareness of the risk for general population, high-risk 
group such as healthcare workers. The results also show 
the need to propose new training courses for the future, 
such as our sample suggested (58.33%, n = 42). However, 
Johnson previously described the healthcare profession-
als’ lack of knowledge that we confirm in our sample. In 
particular only 2.78% (n = 2) of the subjects consulted 
the institutional web pages, 6.94% (n  =  5) referred to 
ministerial disposal, and 11.11% (n = 8) read scientific 
articles. Recently, due to the low influenza coverage rate 
among Italian healthcare professionals, Alicino et al. 
conducted an educational project. The study was aimed 
to increase knowledge on influenza burden, risk of pa-
tients’ infection from healthcare workers, and the immu-
nization benefits [9]. The intervention was carried on for 
eight consecutives influenza seasons and was based on 
several courses, informative materials, and easier access 
for healthcare workers’ immunization. Although during 
the whole period, the coverage rate had had a discontinu-
ous trend, however the multicomponent intervention re-
sulted in a significant increase of the influenza coverage 
rate. Recent evidences show as continuing education, 
incentives after immunization, easier access to vaccina-
tion are key strategies in increasing vaccination cover-
age among health care workers [22-24]. 
However, the study has some limitations. Firstly the 
small sample, although we obtained a good response rate 
compare to previous study, where the respondents were 
around 3% among general practitioners [20]. Secondly, 
the questionnaire was a self-administered, and suffer for 
the classical limitations of the survey such as social de-
sirability bias and recall bias. However, we conducted 
an on-line survey that is associated with a lower social 
desirability bias compared with traditional version [25]. 
Thirdly, the vaccination history was self-reported and we 
did not check the pharmacists’ vaccination status, due to 
the anonymous version of the survey. Nevertheless, there 
are indisputable advantages in the use of the question-
naire. It is a cheaper and easy tool, such as manageable 
for both respondents and researchers. Nonetheless, our 
study has also some strengths such as the use of previ-
ously validated questionnaire and the use of web-based 
questionnaire. Further, to the best of our knowledge it is 
the first study aimed to understand knowledge, attitude 
and behaviour on influenza vaccine among Italian phar-
macists. 
Conclusions
The aim of our study was to verify the knowledge and 
attitude of pharmacists on influenza vaccination. The 
results shown a low grade of awareness regarding the 
important role that pharmacists might play in order to re-
duce influenza burden, to promote health literacy among 
their patients, to decrease the risk of patients infection. 
In our opinion, pharmacists might be crucial healthcare 
workers involved in health promotion, in vaccines’ up-
take and practices progression. However, it is essential 
to plan a training courses tailored for healthcare workers. 
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